Ditchcarbon
  • Contact
  1. Organizations
  2. Quanta Dialysis Technologies Limited
Public Profile
Medical Device Manufacturing
GB
updated a month ago

Quanta Dialysis Technologies Limited Sustainability Profile

Company website

Quanta Dialysis Technologies Limited, a pioneering name in the renal care industry, is headquartered in Great Britain. Founded in 2012, the company has rapidly established itself as a leader in innovative dialysis solutions, focusing on home and hospital-based treatments. Quanta's flagship product, the SC+ dialysis system, stands out for its compact design and user-friendly interface, enabling greater patient autonomy and improved quality of life. With a commitment to advancing renal care, Quanta operates across Europe and is expanding its reach globally. The company has achieved significant milestones, including regulatory approvals and partnerships that enhance its market position. Quanta Dialysis Technologies is dedicated to transforming the dialysis experience, making it more accessible and efficient for patients worldwide.

DitchCarbon Score

How does Quanta Dialysis Technologies Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

26

Industry Average

Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Quanta Dialysis Technologies Limited's score of 26 is lower than 57% of the industry. This can give you a sense of how well the company is doing compared to its peers.

43%

Let us know if this data was useful to you

Quanta Dialysis Technologies Limited's reported carbon emissions

Quanta Dialysis Technologies Limited, headquartered in Great Britain, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of emissions data and climate commitments suggests that Quanta Dialysis Technologies may not yet have established a formal framework for addressing its carbon footprint or engaging in sustainability initiatives. As the industry increasingly prioritises climate action, it will be essential for the company to consider developing measurable targets and strategies to align with global climate goals.

How Carbon Intensive is Quanta Dialysis Technologies Limited's Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Quanta Dialysis Technologies Limited's primary industry is Medical Device Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Quanta Dialysis Technologies Limited's Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Quanta Dialysis Technologies Limited is in GB, which has a very low grid carbon intensity relative to other regions.

Quanta Dialysis Technologies Limited's Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Quanta Dialysis Technologies Limited has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Quanta Dialysis Technologies Limited's Emissions with Industry Peers

B. Braun Medical Inc.

US
•
Medical, precision and optical instruments, watches and clocks (33)
Updated 29 days ago

Roche Holding AG

CH
•
Pharmaceutical Preparation Manufacturing
Updated 6 days ago

Ardelyx, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 6 days ago

B. Braun Melsungen AG

DE
•
Medical, precision and optical instruments, watches and clocks (33)
Updated 5 days ago

Baxter

US
•
Medical, precision and optical instruments, watches and clocks (33)
Updated 4 days ago

Akebia Therapeutics, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 6 days ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251107.1
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy